NDC product
Alfuzosin Hydrochloride
NDC 65862-249 · Aurobindo Pharma Limited
Key facts
| Product NDC | 65862-249 |
|---|---|
| Proprietary name | Alfuzosin Hydrochloride |
| Nonproprietary name | Alfuzosin Hydrochloride |
| Substances | ALFUZOSIN HYDROCHLORIDE |
| Dosage form | TABLET, FILM COATED, EXTENDED RELEASE |
| Route | ORAL |
| Labeler | Aurobindo Pharma Limited |
| Product type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Application number | ANDA079060 |
| Pharmacologic classes | Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC] |
| Marketing start | Aug 30, 2012 |
| Listing certified through | Dec 31, 2027 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: